Tumor hypoxia is a common feature of prostate tumors associated with the stabilization of hypoxia-inducible-factor 1alpha (HIF-1α) and poor prognosis following radiation therapy. Lack of oxygen at the time of irradiation is associated with radioresistance, but recent reports suggest radioresponse is also modulated by the dynamic nature of tumor hypoxia.
Derek Hennessey, Lynn Martin, Anne Atzberger, Thomas Lynch, Donal Hollywood and Laure Marignol
Superficial radiation therapy treatment provides a non-surgical option for patients with basal cell carcinoma, squamous cell carcinoma, and keloid scarring. In this webcast, Dr. Colin Dicks, Radiation Oncologist from Just Skin in Australia, describes more about the...